“Reports of my death [may be] greatly exaggerated” (adapted from mark twain)—In response to Dr. J. M. Brown, IJROBP 32:883

“Reports of my death [may be] greatly exaggerated” (adapted from mark twain)—In response to Dr. J. M. Brown, IJROBP 32:883–885; 1995

Published:1995-07 Issue:4 Volume:32 Page:1264-1265
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Coleman C. Norman

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference9 articles.

1. Hypoxic cell radiosensitizers: the end of an era?;Brown;Int. J. Radiat. Oncol. Biol. Phys.,1995

2. The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: Results from a Phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer;Coleman;Int. J. Radiat. Oncol. Biol. Phys.,1992

3. A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: An interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix;Dische;Radiother. Oncol.,1993

4. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy alone for locally advanced head and neck carcinomas;Lee;Int. J. Radiat. Oncol. Biol. Phys.,1995

5. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity of 5-fluorocytosine: A negative selection system;Mullen,1992

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitizers and protectors of radiation and chemotherapy;Current Problems in Cancer;2001-11

2. Pharmacokinetic monitoring and dose modification of Etanidazole in the RTOG 85-27 phase III head and neck trial;International Journal of Radiation Oncology*Biology*Physics;1997-11